Skip to content

Real-world performance evaluation of PreSize Neurovascular medical software in a clinical setting

Real-world performance evaluation of PreSize Neurovascular medical software in a clinical setting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17947655
Enrollment
100
Registered
2022-05-12
Start date
2022-08-04
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial aneurysm Circulatory System

Interventions

Study design: Post-market, multi-centre, prospective, non-randomised study Summary of the study procedures: Study interventional neuroradiologists (INRs) will plan flow diverter (FD) brain stenting p

Sponsors

Oxford Heartbeat Ltd
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 150 Years

Inclusion criteria

Inclusion criteria: 1. Adults aged 18 years or above 2. Indicated to receive treatment for an intracranial aneurysm with one of the FDs compatible with PreSize Neurovascular at one of the participating NHS sites 3. Able to receive both pre-operative 3D rotational angiography (3DRA) and post-operative 2D digital subtraction angiography (2DSA) or cone-beam computed tomography (CT), excluding allergy to iodinated contrast media

Exclusion criteria

Exclusion criteria: 1. Any reasons in the opinion of the investigator, e.g. patient cases previously fitted with coiling in the same aneurysmal area might be deemed inappropriate for the purposes of this study if it significantly impacts the contrast in the pre-operative X-ray imaging 2. Unable to give informed consent

Design outcomes

Primary

MeasureTime frame
1. PreSize Neurovascular accuracy at simulating stent length when the software is used in real clinical practice. Accuracy will be assessed by comparing the simulated deployed stent length estimated by PreSize Neurovascular software using pre-operative imaging and the observed deployed stent length from post-operative imaging.

Secondary

MeasureTime frame
1. Discrepancy in stent devices (make, length, diameter) selected when at the pre-operative planning stage INRs use traditional planning methods versus when they use PreSize Neurovascular 2. INR satisfaction with the software measured using post-procedural short periodic surveys and qualitative interviews with each INR 3. Planning duration when INRs use traditional planning methods versus when they use PreSize Neurovascular software. The planning duration for the two approaches will be recorded in real-time at the pre-operative stage. 4. Procedure duration and radiation dose during the procedure in cases planned with PreSize Neurovascular. Duration will be measured by timestamps in intra-operative imaging and radiation dose will be recorded post-procedure. The same measures will be collected from historical data from past procedures. 5. Intra-operative corrections, defined as devices deployed additionally and discarded as well as manual manipulations by INRs due to suboptimal stent fit observed in cases planned using PreSize Neurovascular. The corrections will be recorded post-procedure. The same measures will be collected from historical data from past procedures.

Countries

England, Scotland, United Kingdom, Wales

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 7, 2026